Allianz Asset Management
RPRX

Allianz Asset Management’s Repros Therapeutics Inc. RPRX Stock Holding History

Allianz Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-63,919
Closed -$633K – 2493
2014
Q3 		$633K Buy
63,919
+8,008
+14% +$119K ﹤0.01% 1821
2014
Q2 		$967K Sell
55,911
-314
-0.6% -$5.12K ﹤0.01% 1408
2014
Q1 		$997K Sell
56,225
-3,412
-6% -$66K ﹤0.01% 1405
2013
Q4 		$1.09M Sell
59,637
-3,423
-5% -$64.6K ﹤0.01% 1378
2013
Q3 		$1.69M Buy
+63,060
New +$1.35M ﹤0.01% 1233

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management's RPRX Position: Q4 2014 in Review

Allianz Asset Management sold out of Repros Therapeutics Inc. (RPRX) in Q4 2014, closing a stake of 63,919 shares — an estimated $633K sold.

Allianz Asset Management first reported a position in RPRX in Q3 2013 and held it in 5 quarters. The position peaked at $1.69M in Q3 2013. 80 funds tracked by Wall St. Rank hold RPRX as of Q4 2014.

  • Allianz Asset Management reported no remaining Repros Therapeutics Inc. position as of Q4 2014 after selling out during the quarter.
  • Allianz Asset Management sold 63,919 Repros Therapeutics Inc. shares in Q4 2014, an estimated $633K.
  • Allianz Asset Management first reported a position in Repros Therapeutics Inc. in Q3 2013 and held it in 5 quarters.
  • Allianz Asset Management's Repros Therapeutics Inc. position peaked at $1.69M in Q3 2013.
  • 80 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2014.

Based on Allianz Asset Management's 13F filing for Q4 2014, filed 17 Feb 2015.